Activest Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Activest Wealth Management's XBI Position: Q3 2026 in Review
Activest Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 9.7% in Q3 2026, buying an estimated $5.05K and bringing the position to 361 shares worth $56.8K. The position accounts for 0.01% of the portfolio, ranked #250.
Activest Wealth Management first reported a position in XBI in Q1 2021 and has held it in 18 quarters since. The position peaked at $153K in Q1 2021. 962 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Activest Wealth Management held 361 shares of State Street SPDR S&P Biotech ETF worth $56.8K as of Q3 2026.
- Activest Wealth Management bought 32 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $5.05K.
- State Street SPDR S&P Biotech ETF made up 0.01% of Activest Wealth Management's portfolio in Q3 2026, its #250 holding.
- Activest Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 18 quarters since.
- Activest Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $153K in Q1 2021.
- 962 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.